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Abstract Here, we report that an E-box element located within
the human topoisomerase IIIK (hTOP3K) gene promoter acts as
a cell type-specific enhancer. The upstream stimulatory factor
(USF) was shown to specifically recognize the mutationally
sensitive E-box element. When assayed by transient transfection
with hTOP3K promoter-dependent reporter genes, USF is
transcriptionally active in HeLa cells but lacks transcriptional
activity in Saos-2 cells. The hTOP3K mRNA level in Saos-2 cells
was reduced to about 30% of the level observed for HeLa cells,
suggesting that the inactivity of USF in hTOP3K promoter
activity may be the cause of the marked reduction of hTOP3K
mRNA levels in Saos-2 cells. Using transient transfection assays
in HeLa cells, we demonstrated that ectopically expressed USF2,
but not USF1, was capable of activating hTOP3K transcription
through the E-box element. However, USF2 did not stimulate
hTOP3K promoter activity in Saos-2 cells. This cell type-specific
regulation of promoter activity by USF2 may provide a
mechanism for the differential expression of hTOP3K in various
tissues and during developmental stages. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
DNA topoisomerases are ubiquitous nuclear enzymes that
are able to catalyze changes in the topological state of DNA
[1^4]. Type I topoisomerases catalyze the removal of positive
and negative supercoils by transiently breaking one strand of
the DNA double helix [5]. These enzymes are further divided
into two subfamilies, IA and IB, based on di¡erences in their
reaction mechanisms [6,7]. The type IA subfamily contains
archaebacterial reverse gyrase, bacterial topoisomerase I and
III, and eukaryotic topoisomerase III, and all enzymes link
covalently to the 5P-end of the cleaved DNA strand via a
phosphotyrosine bond. This mechanism clearly distinguishes
the type IA from type IB enzymes, which bind at the 3P-end of
the cleaved DNA.
A cDNA encoding human topoisomerase IIIK (hTOP3K)
was cloned in 1996, and its gene locus was mapped to chro-
mosome 17p11.2^12 [8]. Overexpression of a truncated form
or an antisense construct of hTOP3K was found to inhibit
spontaneous and radiation-induced apoptosis upon transfec-
tion into ataxia-telangiectasia (A-T) ¢broblasts, whereas a
full-length sense construct failed to suppress apoptosis [9].
These results suggested that the hTOP3K may be deregulated
in A-T cells and involved in maintaining genomic stability,
perhaps in concert with Bloom’s or Werner’s syndrome
DNA helicases [10,11]. Targeted disruption of the mouse
TOP3K gene revealed that this gene is essential in early em-
bryogenesis [12]. The requirement of TOP3K for viability
might be due to its plausible roles in DNA replication and
its interaction with the RecQ/SGS1 family of DNA helicases.
Although endogenous expression of the hTOP3K gene was
found in multiple somatic tissues [9], the transcriptional mech-
anisms involved in hTOP3K gene expression remain poorly
understood. Previously, we have shown that the hTOP3K
gene promoter region from 3326 to +82 (+1 is transcription
initiation site) was su⁄cient to support the promoter activity
[13]. On the basis of gel mobility shift and supershift assays,
we have de¢ned a mutationally sensitive E-box element within
the hTOP3K gene promoter. This E-box element is capable of
binding in vitro to the upstream stimulatory factor (USF),
which functions as an activator of hTOP3K transcription.
Here, we demonstrate that USF2, but not USF1, in HeLa
cells is capable of stimulating hTOP3K transcription activity
through the E-box. However, cotransfection of USF2 with
hTOP3K promoter^reporter gene in Saos-2 cells did not alter
reporter gene activity from the level observed in the absence
of ectopically expressed USF. Therefore, we propose that the
mutationally sensitive E-box element functions as a cell type-
speci¢c enhancer of hTOP3K promoter activity.
2. Materials and methods
2.1. DNA constructs
The chimeric construct (wild-type 3326LUC) containing the 5P-
£anking region of the hTOP3K gene was constructed by inserting
DNA fragments between the KpnI and BglII sites of the pGL2 vector
(Promega) as described previously [13]. Site-directed E-box mutant
construct (E-box mut 3326LUC) was generated by polymerase chain
reaction (PCR) using wild-type 3326LUC as a template and the prim-
ers, 5P-CGGGGTACCGGATCCTGCTACCGCGGCGCCGCCAT-
CTTGACAGGTAATGACTCC-3P (bases 3326 to 3280 from the
transcription initiation site) and 5P-GAAGATCTTCACTGAGC-
CTTTCCCGTGCCGC-3P (bases +60 to +82). PCR products were
digested with KpnI and BglII to release the 3326/+82 mutated frag-
ment and ligated into pGL2.
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2.2. Transfection and luciferase expression assays
Cells plated onto six-well plates were grown to 70% con£uence
prior to transfection. 2 Wg of test constructs were cotransfected with
2 Wg of L-galactosidase expression plasmid, pCH110 (Amersham
Pharmacia Biotech) using LipofectAMINE (Life Technologies) ac-
cording to the manufacturer’s protocol. Luciferase and L-galactosi-
dase assays were performed exactly as described [13]. The luciferase
activities were normalized with the L-galactosidase activities.
2.3. Northern hybridization analysis
Total cellular RNA was isolated from exponentially growing cells
using Tri reagent (Molecular Research Center). RNA samples (10 Wg/
lane) were separated on a 1% formaldehyde^agarose gel and vacuum
transferred to Hybond N membrane (Amersham-Pharmacia Bio-
tech). A probe consisting of a full-length hTOP3K cDNA was labeled
with [K-32P]dCTP (Amersham Pharmacia Biotech) to a speci¢c activ-
ity of 1U108 cpm/Wg using a random-primed DNA labeling system
(Amersham Pharmacia Biotech). Control hybridization was carried
out using a labeled glyceraldehyde-3-phosphate dehydrogenase probe.
2.4. Nuclear extracts and electrophoretic mobility shift assays
Nuclear extracts were prepared according to the method of Dignam
et al. [14]. For electrophoretic mobility shift assay, duplex probes were
end-labeled by ¢lling in with Klenow DNA polymerase and
[K-32P]dCTP. Approximately 1 ng of the labeled probe was mixed
with 2.4 Wg of nuclear proteins. After incubation on ice for 20 min,
the reaction mixture was separated on a 6% non-denaturing poly-
acrylamide gel. The gel was dried and subjected to autoradiography.
For supershift experiments, 0.2 Wg of antibody (Santa Cruz Biotech-
nology) was added to the mixture 20 min prior to the addition of
labeled probe, and the mixture was further incubated for 20 min at
room temperature.
3. Results
3.1. USF transactivation of the hTOP3K promoter is active
in HeLa cells, but not in Saos-2 cells
Recently, Qyang et al. reported the cell type-dependent ac-
tivity of USF in cellular proliferation and transcriptional ac-
tivation [15]. The USF proteins are transcriptionally active in
HeLa cells but do not function in Saos-2 cells as transcrip-
tional e¡ectors. Our previous work has shown that an E-box
element located within the hTOP3K gene promoter serves as a
binding site for USF in vitro [13]. This initial observation
prompted us to examine whether USF function on the acti-
vation of hTOP3K gene transcription is cell type-dependent.
We mutated the hTOP3K promoter by site-directed mutagen-
esis at the E-box (Fig. 1A). Wild-type (3326LUC) or mutant
(E-box mut 3326LUC) plasmid was transfected into HeLa
cells, and luciferase activity was measured from the cell ly-
sates. The mutation at the E-box reduced the luciferase gene
expression by about 40% when compared with wild-type pro-
moter, indicating that the E-box functions as a positive regu-
latory element for the expression of the hTOP3K gene (Fig.
1C). In contrast, when the promoter activity of the E-box
mutant construct was examined by transient transfection
into Saos-2 cells, no reduction of luciferase activity was ob-
served as compared to the basal level obtained with wild-type
promoter (Fig. 1D). These results suggest that endogenous
Fig. 1. The E-box element in the hTOP3K promoter is active in HeLa cells but inactive in Saos-2 cells. A: DNA sequences of the wild-type
and mutant E-box. B: Wild-type (WT 3326LUC) and E-box mutant (E-box mut 3326LUC) hTOP3K reporter constructs are shown with se-
lected regulatory motifs indicated. YY1 and four SP1-binding sites are also shown. HeLa (C) and Saos-2 cells (D) were transfected with the in-
dicated hTOP3K reporter constructs, and the promoter function was assessed. The amount of the cell lysate employed for each luciferase activ-
ity assay was normalized to the L-galactosidase activity, and the relative luciferase activity of each construct was expressed as a percentage of
that of wild-type construct. The data represent the average of four independent experiments.
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USF can activate the E-box of the hTOP3K promoter in
HeLa cells but is completely inactive in the hTOP3K promoter
of Saos-2 cells.
3.2. Endogenous level of hTOP3K mRNA is reduced in
Saos-2 cells
Since the E-box element acts as a cell type-speci¢c enhancer
of hTOP3K promoter activity, we reasoned that endogenous
hTOP3K mRNA levels would be lower in Saos-2 cells as
compared to HeLa cells. To test this possibility, we performed
Northern blot analysis with total RNA prepared from the two
cell lines. Northern blots were hybridized with a probe con-
sisting of a full-length hTOP3K cDNA. One distinct hTOP3K
transcript of about 3.8 kb and a smear of larger transcripts
were detected, and the level of hTOP3K mRNA in Saos-2 cells
was reduced to about 30% of that observed for HeLa cells
(Fig. 2). This result suggests that the inability of USF to
activate the hTOP3K promoter in Saos-2 cells may directly
account for the marked reduction in hTOP3K mRNA level
in these cells.
3.3. Expression and DNA binding activity of the endogenous
USF proteins in HeLa and Saos-2 cells
The above-mentioned ¢ndings suggest that the cell type-de-
pendent transcription activity of hTOP3K gene between HeLa
Fig. 2. Northern analysis of hTOP3K mRNA levels in HeLa and
Saos-2 cells. A: Relative expression of hTOP3K mRNA. Data
shown are averages of three separate experiments. The relative band
intensities on Northern blots were determined with a phosphoimag-
ing analyzer. B: Representative Northern blot showing expression
of hTOP3K. RNA samples were separated on 1% formaldehyde^
agarose gel, transferred to membrane, and probed with a full-length
hTOP3K cDNA. A human glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) cDNA probe was used for normalization of gel
loading.
Fig. 3. Expression and DNA-binding activity of endogenous USF1 and USF2 in HeLa and Saos-2 cells. A: Western blot analysis was per-
formed with nuclear extracts prepared from HeLa and Saos-2 cells to compare the endogenous levels of USF1 and USF2 present in both cells.
B: The 52-bp radiolabeled duplex probe (1 ng) extending from 3275 to 3326 was incubated with 2.4 Wg of HeLa or Saos-2 cell nuclear ex-
tracts (lanes 2 and 8) in the binding mixture containing antibody against YY1 (lanes 3 and 9), USF1 (lanes 4 and 10), USF2 (lanes 5 and 11),
or USF1 plus USF2 (lanes 6 and 12). Lanes 1 and 7 contained probe alone. Bands A, B, and BP represent speci¢c protein^DNA complexes.
Anti-USF1 antibody generated the rapidly migrating supershifted complex (indicated by the open circle), and anti-USF2 antibody generated
the slower-migrating supershifted complex (indicated by the closed circle).
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and Saos-2 cells may be due to di¡erences in the expression
and DNA-binding activity of the USF proteins. To address
this possibility, we measured the amounts of the endogenous
USF proteins in nuclear extracts from HeLa and Saos-2 cells
prepared under identical conditions. Western blot analysis of
the USF protein contents of the two cell lines revealed that
both contain similar amounts of USF1 and USF2 (Fig. 3A).
We next determined USF DNA-binding activities in the two
cell lines by electrophoretic mobility shift assay (EMSA) using
the extended E-box, consisting of the 52-bp region extending
from 3275 to 3326 upstream of transcription initiation in the
hTOP3K promoter, as a probe. This 52-bp region was shown
to serve as the binding sites for both YY1 and USF [13]. As
shown in Fig. 3B, nuclear extracts derived from HeLa and
Saos-2 cells formed three major DNA^protein complexes
(lanes 2 and 8). The speci¢city of these complexes for the
probe was shown by supershift analysis. Preincubation with
the anti-YY1 antibody selectively reduced the level of complex
B, but had no e¡ect on complex A (lanes 3 and 9). The com-
plex BP most likely contained proteolytic degradation prod-
ucts of YY1, as it was also supershifted by the anti-YY1 anti-
body. YY1 has been previously reported to be susceptible to
proteolytic degradation [16]. Conversely, preincubation with
the anti-USF1 antibody completely inhibited the formation of
complex A and generated a distinct supershifted complex in
both cell lines, but did not a¡ect the formation of complexes
B and BP (lanes 4 and 10). This result suggests that complex A
contained USF1 homodimers and USF1-USF2 heterodimers
in the two cell lines. When anti-USF2 antibody was preincu-
bated with nuclear extracts, the formation of complex A was
partially inhibited and a further supershifted complex was
generated (lanes 5 and 11). Complex A did not completely
disappear even when excess amounts of anti-USF2 antibody
were added to the reactions (data not shown). The addition of
both USF1 and USF2 antibodies together completely elimi-
nated USF-containing complexes and generated two distinct
supershifted complexes (lanes 6 and 12). Taken together, these
data indicate that similar USF DNA-binding activities are
present in the two cell lines. From these results, we conclude
that the inability of the USF proteins to activate hTOP3K
transcription in Saos-2 cells is not due to a lack of expression
or DNA-binding activity of the USF proteins.
3.4. Expression of USF2 enhances hTOP3K transcription
activity in HeLa cells but not in Saos-2 cells
HeLa and Saos-2 cells were cotransfected with hTOP3K
promoter^reporter constructs (3326LUC), together with ei-
ther a USF1 or USF2 expression vector or both. When
Fig. 4. Ectopically expressed USF2 enhances hTOP3K transcription activity in HeLa cells but not in Saos-2 cells. HeLa (A) or Saos-2 cells (B)
were transfected with the 3326LUC reporter plasmid and the indicated USF expression vectors. The amount of the cell lysate employed for
each luciferase activity assay was normalized to the L-galactosidase activity, and the relative luciferase activity of each construct was expressed
as a percentage of that of the corresponding empty vector. The data represent the average of four independent experiments. C: The levels of
expression of the various USF proteins were measured by Western blot analysis with the same extracts used in luciferase assays.
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USF1 was ectopically expressed in HeLa cells, transcription
activity of the 3326LUC reporter was not enhanced over the
basal level obtained in the absence of exogenous USF (Fig.
4A). In marked contrast, ectopically expressed USF2 acti-
vated the 3326LUC reporter about 2.7-fold. This activation
was mediated through the E-box since the hTOP3K promoter
with a mutated E-box (E-box mut 3326LUC) was unrespon-
sive to exogenous USF2 (data not shown). Furthermore, tran-
scription activation of the 3326LUC reporter in the presence
of USF2 was decreased by cotransfecting USF1. Such reduc-
tion would be induced because overexpressed USF1 is shifting
the equilibrium of USF dimer compositions and competing
o¡ the USF2 homodimers. When the same experiments were
performed in Saos-2 cells, cotransfection of either a USF1 or
USF2 expression vector or both with the 3326LUC reporter
did not enhance hTOP3K promoter activity over the basal
level (Fig. 4B). These results suggest that the exogenous
USF proteins were completely inactive and were incapable
of activating hTOP3K transcription in Saos-2 cells.
The highly conserved USF-speci¢c region (USR) of USF2
acts as an autonomous transcriptional activation domain at
promoters containing an initiator element [15,17]. Since the
sequence surrounding the transcription initiation site of the
hTOP3K promoter is homologous to the initiator consensus
sequence [13], we examined the role of the USR in the acti-
vation of the hTOP3K promoter by USF2. HeLa cells were
cotransfected with the 3326LUC reporter, together with a
USF2 mutant construct lacking only the USR (U2vUSR).
Overexpression of U2vUSR did not alter 3326LUC tran-
scription from the level observed in the absence of ectopically
expressed USF, indicating that the USR of USF2 is required
to activate the hTOP3K promoter in HeLa cells (Fig. 4A).
Furthermore, cotransfection of U2vUSR reduced transcrip-
tional activation by USF2 to about 60% of the activity ob-
served with USF2 alone. These experiments suggest that
U2vUSR functions as a dominant-negative regulator of
E-box-dependent enhancer activity in hTOP3K promoter. In
Saos-2 cells, cotransfection of U2vUSR did not signi¢cantly
alter 3326LUC transcription activity from the level observed
in the presence of either USF1 or USF2 alone (Fig. 4B). The
overexpression levels of exogenous USF variants produced by
transient transfection were examined by Western blot analysis.
As shown in Fig. 4C, the levels of USF expression were found
to be similar between the two cell lines. These data further
con¢rmed that the inability of exogenous USF proteins in
Saos-2 cells was not due to a lack of expression in transfected
cells.
3.5. Transactivating e¡ects of increasing amounts of the USF
expression vectors
When the transcription activators are expressed at very high
levels, trans-activation could be diminished due to the self-
squelching e¡ect through which inhibitory protein interactions
can occur [18^20]. Thus, it would be possible that the inability
of the USF proteins in Saos-2 cells could be due to the self-
squelching e¡ect when overexpressed. To address this point,
the 3326LUC reporter construct was cotransfected into HeLa
and Saos-2 cells with increasing amounts of USF expression
vectors. In HeLa cells, reporter gene expression activity in-
creased with increasing amounts of USF2 concentrations
(up to 0.5 Wg of expression vectors), while increasing the con-
centration of USF1 did not activate reporter activity (Fig.
5A). Consistent with the results shown in Fig. 4, transactiva-
tion by USF2 was decreased by cotransfecting increasing con-
centrations of USF1. A squelching phenomenon was observed
at elevated concentrations of USF proteins. However, increas-
ing the concentration of overexpressed USF2 in Saos-2 cells
had no e¡ect on the activity of the cotransfected reporter (Fig.
5B). The overexpression levels of the exogenous USF proteins
were examined by Western blot analysis and were found to be
similar (data not shown).
4. Discussion
Although endogenous expression of mammalian TOP3K
gene is di¡erentially regulated in di¡erent tissues and during
developmental stages [21,22], very little is known about the
molecular mechanisms involved in the transcriptional regula-
tion of the TOP3K gene. Recently though, we demonstrated
that both YY1 and USF transcription factors bind to the
TOP3K promoter and function as transcriptional activators
[13,23]. Since the USF proteins have been recognized as im-
portant players in the regulation of tissue-speci¢c genes [24]
and in the speci¢c response of genes to external modulators
[25], it seems of interest to examine whether the USF proteins
functionally regulate the transcription activity of hTOP3K
gene in a cell type-speci¢c manner. Mutation of a consensus
binding site for USF was shown to markedly decrease
Fig. 5. Transactivating e¡ects of the USF expression vectors. HeLa (A) and Saos-2 cells (B) were transfected with the 3326LUC reporter plas-
mid and various amounts of either USF1, or USF2, or USF1 plus USF2 expression vectors, as indicated. Luciferase activity was measured as
described in the legend to Fig. 4. The results of the luciferase assay are expressed as fold activation over the basal level observed in the absence
of a USF expression vector. The data represent the average of four independent experiments.
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hTOP3K promoter activity in HeLa cells, indicating that USF
is transcriptionally active and essential for the high level ex-
pression of the hTOP3K gene. In contrast, USF lacks tran-
scriptional activity in Saos-2 cells. These data demonstrate
that USF functionally regulates the expression of the hTOP3K
gene and acts as a cell type-speci¢c regulator of hTOP3K
promoter activity.
Using transient transfection assays, we demonstrated that
USF2 in HeLa cells was able to activate transcription of the
reporter gene driven by the hTOP3K promoter through the
E-box element. In contrast, USF1 overexpression had no
e¡ect on hTOP3K promoter activity. Furthermore, coexpres-
sion of ectopic USF1 and USF2 is less potent than over-
expression of USF2 alone. The USF1 and USF2 proteins
are ubiquitously expressed in many cell types. However, rela-
tive ratios of USF homo- and heterodimers are known to vary
among di¡erent cell types [26]. Although the e¡ect of the
di¡erent compositions of endogenous USF dimers on
hTOP3K promoter activity has not been extensively examined,
it appears more likely that USF2 homodimers are more po-
tent transactivator than other USF species in HeLa cells.
Cotransfection of USF2 with hTOP3K promoter^reporter
construct in Saos-2 cells did not enhance hTOP3K promoter
activity over the basal level. Thus, the critical question that
remains to be answered is why USF2 was completely inactive
and failed to activate transcription of the hTOP3K gene in
Saos-2 cells. Recently, Qyang et al. reported a cell type-de-
pendent activity of the USF proteins in cellular proliferation
and transcriptional activation [15]. Consistent with our ¢nd-
ings, they demonstrated that the USF proteins in HeLa cells
function as transcriptional e¡ectors and their overexpression
causes marked growth inhibition, but the USF proteins in
Saos-2 cells are transcriptionally inactive. The inactivity of
the USF proteins in Saos-2 cells on the promoters examined
was not due to a de¢ciency of transcription factors since USF
and other transcription factors were present in both Saos-2
and HeLa cells. The coactivator model was proposed to ac-
count for the complete inactivity of USF in Saos-2 cells [15].
In this model, the transcription activity of USF is controlled
by interaction of a speci¢c coactivator that could not be ex-
pressed in Saos-2 cells. Although this cellular activator has
not been identi¢ed yet, transcriptional activation of the
hTOP3K gene through the E-box element is consistent with
the coactivator model for cell type-dependent activity of USF.
In summary, the present study suggests that USF2 is capa-
ble of enhancing promoter activity of the hTOP3K gene
through the upstream E-box element in a cell type-speci¢c
manner. USF2 functions as a transactivator of the hTOP3K
promoter in HeLa cells but are completely inactive in Saos-2
cells. This cell type-speci¢c regulation by USF2 may, at least
in part, provide a mechanism for the di¡erential expression of
hTOP3K gene in various tissues and during developmental
stages.
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